Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris
Clinical trial NCT01880320 · COMPLETED
Trial details
- NCT number
- NCT01880320
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.